Plastic phenotype of human oligodendroglial tumour cells in vitro

Neuropathology and Applied Neurobiology

Volumn 22, Issue 4, 1996, Pages 302-310

  Tenenbaum, L ^a   Teugels, E ^a   Dogusan, Z ^a   Avellana Adalid, V ^b   Hooghe Peters, E L ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

A2B5; Differentiation; GFAP; O1; Oligodendroglioma; Proliferation; SCIP

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; INSULIN; PLATELET DERIVED GROWTH FACTOR;

ARTICLE; ASTROCYTE; CELL PROLIFERATION; CULTURE MEDIUM; DNA REPLICATION; HUMAN; HUMAN CELL; MEMBRANE MARKER; NERVE CELL DIFFERENTIATION; OLIGODENDROGLIA; OLIGODENDROGLIOMA; PHENOTYPE; PRIORITY JOURNAL; STEM CELL; TUMOR CELL CULTURE;

EID: 0029763243     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2990.1996.tb01108.x     Document Type: Article

References (38)

1. Armstrong RC, Dorn HH, Kufta CV, Friedman E, Dubois-Dalcq ME. Preoligodendrocytes from Adult Human CNS. J Neurosci 1992; 12: 1538-47
2. Barres BA, Hart DC, Coles SR et al. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 1992; 70: 31-46
3. Bögler O, Wren D, Barnett SC, Land H, Noble M. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type 2 astrocytes (O-2 A) progenitor cells. Proc Natl Acad Sci USA 1990; 87: 6368-72
4. Botenstein JE. Growth requirements in vitro of oligodendrocyte cell lines and neonatal rat brain oligodendrocytes. Proc Natl Acad Sci USA 1986; 83: 1955-9
5. Botenstein JE, Sato GH. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci USA 1979; 76: 514-7
6. Collarini EJ, Kuhn R, Marshall CJ, Monuki ES, Lemke G, Richardson WD. Down-regulation of the POU transcription factor SCIP is an early event in oligodendrocyte differentiation in vitro. Development 1992; 116: 193-200
7. Choi BH, Kim RC. Expression of glial fibrillary acidic protein in immature oligodendroglia. Science 1984; 223: 407-9
8. Darling JL, Brain. In Human Cancer in Primary Culture. Ed. Maslers JRW. Dordrecht: Klower Academic Publishers, 1991: 231-51
9. de la Monte S. Uniform lineage of oligodendrogliomas. Am J Pathol 1989; 135: 529-40
10. Delhase M, Vergani P, Malur A, Velkeniers B, Teugels E, Trouillas J, Hooghe-Peters E. Pit 1/GHF-1 expression in pituitary adenomas: further analogy between human adenomas and rat SMtTW tumours. J Mol Endocrinol 1993; 11: 129-39
11. Eisenbarth GS, Walsh FS, Nirenburg M. Monoclonal antibody to a plasma membrane antigen of neurons. Proc Natl Acad Sci USA 1979; 76: 4913-7
12. Eng LF, Rubinstein LJ. Contribution of immunohistochemistry to diagnostic problems of human cerebral tumours. J Histochem Cytochem 1978; 26: 513-22
13. Eng LF, Vanderhaegen JJ, Bignami A, Gerstl B. An acidic protein isolated from flbrillary astrocytes. Brain Res 1971; 28: 351-4
14. Espinosa de los Monteros A, Zhang M, De Vellis J. O-2 A progenitor cells transplanted into the neonatal rat brain develop into oligodendrocytes but not astrocytes. Proc Natl Acad Sci USA 1993; 90: 50-4
15. He X, Treacy MN, Simmons DM, Ingraham HA, Swanson LW, Rosenfeld MG. Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature 1989; 340: 35-42
16. Herpers MJ, Budka H. Glial fibrillary acid protein (GFAP) in oligodendroglial tumours: gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma. Acta Neuropathol (Berl) 1984; 64: 265-72
17. Kashima T, Tiu SN, Merrill JE, Vinters HV, Dawson G, Campagnoni AT. Expression of oligodendrocyte-associated genes in cell lines derived from human gliomas and Neuroblastomas. Cancer Res 1993; 53: 170-5
18. Kennedy PGE., Watkins BA, Thomas DGT, Noble MD. Antigenic expression by cells derived from human gliomas does not correlate with morphological classification. Neuropathol Appl Neurobiol 1987; 13: 327-47
19. Kitajima I, Shinohara T, Biakovics J et al. Ablation of transplanted HTLV-I Tax-transformed tumours in mice by antisense inhibition of NF-κB. Science 1992; 258: 1792-5
20. Kraus JA, Koopmann J, Kaskel P et al. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 1995; 54: 91-5
21. Lumsden CE. The study of tissue culture of tumours of the nervous system. In Russel DS, Rubinstein LJ Eds, Pathology of Tumors of the Central Nervous System. 3rd edn. London: Edward Arnold, 1971: 334-420
22. McKinnon RD, Matsui T, Dubois-Dalcq ME, Aaronson SA. FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 1990; 5: 603-14
23. Monuki ES, Kuhn R, Weinmaster G, Trapp BD, Lemke G. Expression and activity of the POU transcription factor SCIP. Science 1990; 249: 1300-3
24. Morgan D, Freshney RI, Darling JL, Thomas DGT, Celik F. Assay of anticancer drugs in tissue cultures: cell cultures of biopsies from human astrocytoma. Br J Cancer 1983; 47: 205-14
25. Nakagawa Y, Perentes E, Rubinstein LJ. Immunohistochemical characterization of oligodendrogliomas: an analysis of multiple markers. Acta Neuropathol (Berl) 1986; 72: 15-22
26. Ogawa H, Sato Y, Takeshita I, Tateishi J, Kitamura K. Transient expression of glial fibrillary acidic protein in developing oligodendrocytes in vitro. Dev Brain Res 1985; 18: 133-41
27. Ponten J, Westermark B. Properties of human malignant glioma cells in vivo. Med Biol 1978; 56: 184-93
28. Raff M, Miller R, Noble M. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature, 1983; 303: 390-6
29. Ranscht B, Clapshaw PA, Proce J, Noble M, Seifert W. Development of oligodendrocytes and Schwann cells with a monoclonal antibody against galactocerebroside. Proc Natl Acad Sci USA 1982; 79: 2700-13
30. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP. Molecular genetic analysis of oligodendroglial tumours shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994; 145: 1175-90
31. Richardson WD, Pringle N, Mosley MJ, Westermark B, Dubois-Dalcq ME. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 1988; 53: 309-19
32. Richardson WD, Raff M, Noble M. The oligodendrocyte-type-2 astrocyte lineage. Semin Neurosci 1990; 2: 445-54
33. Sarkar C, Roy S, Tandon PN. Oligodendroglial tumours. Cancer 1988; 61: 1862-6
34. Sommer I, Schachner M. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev Biol 1981; 83: 311-27
35. Tenenbaum L. Darling JL, Hooghe-Peters EL. Adeno-associated virus (AAV) as a vector for gene transfer into glial cells of the human central nervous system. Gene Therapy 1994; 1: S80
36. Trojan J, Johnson TR, Rudin SD, Ilan J, Tykocinski ML, Ilan J. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science 1993; 259: 94-6
37. Verzat C, Courriere P, Hollande E. Heterotransplantation of human oligoastrocytoma into nude mice: difference in tumour growth between males and females. Neuropathol Applied Neurobiology 1992; 18: 37-51
38. Warrell RP, Franfel SR, Miller WH et al Differentiation therapy of acute leukemia with tretoin (all-trans-retinoic acid). N Eng J Med 1991; 324: 1385-93